Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98

[1] Collins LC(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[2] Cole KS(2011)Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study Mod Pathol 24 924-931

[3] Marotti JD(2002)Androgens and mammary growth and neoplasia Fertil Steril 77 S26-S33

[4] Hu R(2008)Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors BMC Cancer 8 149-212

[5] Schnitt SJ(2010)Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Mod Pathol 23 205-2341

[6] Tamimi RM(2018)The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome Clin Cancer Res 24 2328-102758

[7] Dimitrakakis C(2017)Post-menopausal breast cancer: from estrogen to androgen receptor Oncotarget 8 102739-1267

[8] Zhou J(2012)Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26 1252-1011

[9] Bondy CA(2012)Elucidating the role of androgen receptor in breast cancer Clin Investig 2 1003-4008

[10] Gonzalez LO(2006)An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene. 25 3994-2712

[1] Collins LC(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[2] Cole KS(2011)Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study Mod Pathol 24 924-931

[3] Marotti JD(2002)Androgens and mammary growth and neoplasia Fertil Steril 77 S26-S33

[4] Hu R(2008)Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors BMC Cancer 8 149-212

[5] Schnitt SJ(2010)Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Mod Pathol 23 205-2341

[6] Tamimi RM(2018)The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome Clin Cancer Res 24 2328-102758

[7] Dimitrakakis C(2017)Post-menopausal breast cancer: from estrogen to androgen receptor Oncotarget 8 102739-1267

[8] Zhou J(2012)Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26 1252-1011

[9] Bondy CA(2012)Elucidating the role of androgen receptor in breast cancer Clin Investig 2 1003-4008

[10] Gonzalez LO(2006)An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene. 25 3994-2712